12:02 PM
Oct 24, 2017
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease


Patient sample and mouse studies suggest inhibiting the ALK-STING axis could help treat sepsis. In patient peripheral blood mononuclear cells (PBMCs), levels of ALK and STING were higher than in PBMCs from healthy volunteers. In mouse models of polymicrobial- and lipopolysaccharide (LPS)-induced sepsis, the oral...

Read the full 217 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >